TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vitalis Pharma AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
9,864
|
9,932
|
9,512 |
Financial expenses |
30
|
39
|
50 |
Earnings before taxes |
2,576
|
1,722
|
2,020 |
Total assets |
4,036
|
5,706
|
4,592 |
Current assets |
797
|
1,899
|
1,611 |
Current liabilities |
723
|
3,110
|
2,939 |
Equity capital |
49
|
256
|
36 |
- share capital |
28
|
30
|
29 |
Employees (average) | 4 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
1.2%
|
4.5%
|
0.8% |
Turnover per employee | 2,466 | ||
Profit as a percentage of turnover |
26.1%
|
17.3%
|
21.2% |
Return on assets (ROA) |
64.6%
|
30.9%
|
45.1% |
Current ratio |
110.2%
|
61.1%
|
54.8% |
Return on equity (ROE) |
5257.1%
|
672.7%
|
5611.1% |
Change turnover |
454
|
-97
|
4,503 |
Change turnover % |
5%
|
-1%
|
90% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.